12 January 2010 - Protagen, a specialist in in-vitro diagnostics and GMP-compliant protein analysis, has appointed two new members to its executive board.
Dr Peter Schulz-Knappe, former chief scientific officer at Proteome Sciences, will take over operational responsibility for the diagnostics business unit.
Martin Bluggel, co-founder and chief operating officer, joins the board and will manage the protein-services business unit.
